Pinnacle Wealth Planning Services’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Pinnacle Wealth Planning Services's JAZZ Position: Q3 2026 in Review
Pinnacle Wealth Planning Services reduced its Jazz Pharmaceuticals (JAZZ) stake by 22% in Q3 2026, selling an estimated $89.4K and leaving 1,275 shares worth $295K. The position accounts for 0.03% of the portfolio, ranked #359.
Pinnacle Wealth Planning Services first reported a position in JAZZ in Q4 2020 and has held it in 6 quarters since. The position peaked at $394K in Q2 2026. 671 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Pinnacle Wealth Planning Services held 1,275 shares of Jazz Pharmaceuticals worth $295K as of Q3 2026.
- Pinnacle Wealth Planning Services sold 362 Jazz Pharmaceuticals shares in Q3 2026, an estimated $89.4K.
- Jazz Pharmaceuticals made up 0.03% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #359 holding.
- Pinnacle Wealth Planning Services first reported a position in Jazz Pharmaceuticals in Q4 2020 and has held it in 6 quarters since.
- Pinnacle Wealth Planning Services's Jazz Pharmaceuticals position peaked at $394K in Q2 2026.
- 671 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.